Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Systemic tetracycline hydrochloride as adjunctive therapy in the treatment of persistent epithelial defects.

Systemic tetracycline hydrochloride as adjunctive therapy in the treatment of persistent epithelial defects. Ophthalmology. 1986 Oct; 93(10):1320-2.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.